EPHESUS was a multicentre , double-blind clinical trial in which @ patients with acute myocardial infarction ( AMI ) complicated by LV systolic dysfunction ( LVSD ) were randomized to receive eplerenone ( n = @ ) or placebo ( n = @ ) .